Insider Sell: 10x Genomics
4:37PM ET 1/14/2022 MT NewswiresBradford Crutchfield, Chief Commercial Officer, on January 12, 2022, sold 17,000 shares in 10x Genomics (TXG) for $2,023,019. Following the Form 4 filing...
Quotes Snapshot > TXG
10X Genomics Inc TXG:NASDAQ
Last Price$90.21Cboe Real-Time Last Sale as of 9:39AM ET 1/27/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.76(1.99%)
Bid (Size)$88.40 (345)
Ask (Size)$90.16 (100)
Day Low / High$90.21 - 91.61
Volume1.3 M
Read more news Recent News
Insider Sell: 10x Genomics
6:06AM ET 1/07/2022 MT NewswiresSerge Saxonov, Director, Chief Executive Officer, on January 04, 2022, sold 15,000 shares in 10x Genomics (TXG) for $2,120,023. Following the Form 4 filing...
Insider Sell: 10x Genomics
5:28PM ET 1/05/2022 MT NewswiresJustin J. McAnear, Chief Financial Officer, on January 03, 2022, sold 10,000 shares in 10x Genomics (TXG) for $1,460,651. Following the Form 4 filing with...
Insider Sell: 10x Genomics
5:25PM ET 1/05/2022 MT NewswiresBenjamin J. Hindson, Director, Chief Scientific Officer and President, on January 03, 2022, sold 41,666 shares in 10x Genomics (TXG) for $6,086,404....
View all Commentary and Analysis
It's Time To Go To Cash For The Next 7 Years - 1-Year Update
2:41PM ET 1/20/2022 Seeking Alpha10x Genomics (TXG) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)
1:14PM ET 1/11/2022 Seeking AlphaReview Of Q3 Earnings For AMR Portfolio (Part 2)
12:28AM ET 12/17/2021 Seeking AlphaARK Innovation ETF: 'Disruption' Needs To Be Diversified To Improve Performance
7:00AM ET 12/14/2021 Seeking AlphaCompany Profile
Business Description
| Number of Employees | N/A |
| Recent SEC Filing | 01/18/2022 SC 13G |
Company Highlights
| Price Open | $91.61 |
| Previous Close | $88.45 |
| 52 Week Range | $81.54 - 208.99 |
| Market Capitalization | $8.3 B |
| Shares Outstanding | 91.6 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 02/16/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$1.58 |
| Beta vs. S&P 500 | N/A |
| Revenue | N/A |
| Net Profit Margin | -99.17% |
| Return on Equity | -59.21% |
Analyst Ratings as of 11/08/2021
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |